Spyre Therapeutics, Inc. (SYRE)

Spyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	64.9	89.42	188.89	34.86	15.14	90.1
Short-Term Investments	421.3	513.67	150.38	20.85	77.99	56.18
Cash & Short-Term Investments	486.2	603.09	339.28	55.71	93.13	146.27
Cash Growth	17.38%	77.76%	509.00%	-40.18%	-36.33%	103.30%
Other Receivables	3.6	-	-	0.38	0.82	-
Receivables	3.6	-	-	0.38	0.82	-
Prepaid Expenses	11.81	5.39	2.25	6.17	4.95	3.52
Other Current Assets	3	-	-	-	-	-
Total Current Assets	504.6	608.47	341.53	62.26	98.89	149.79
Property, Plant & Equipment	-	-	-	7.25	9.15	9.94
Other Long-Term Assets	-	0.01	0.33	1.64	1.88	1.89
Total Assets	504.6	608.48	341.86	71.14	109.93	161.62
Accounts Payable	7.46	0.67	0.9	0.68	3.32	2.25
Accrued Expenses	23.83	27.31	29.2	12.82	13.25	13.41
Current Portion of Leases	-	-	-	0.64	0.85	0.35
Current Unearned Revenue	-	-	-	0.52	2.36	-
Other Current Liabilities	14.99	26.08	1.88	-	0.37	0.44
Total Current Liabilities	46.27	54.06	31.98	14.66	20.14	16.44
Long-Term Leases	-	-	-	4	4.62	5.17
Long-Term Unearned Revenue	-	-	-	2.18	1.22	-
Other Long-Term Liabilities	3.23	36.62	125.87	-	-	0.17
Total Liabilities	49.5	90.68	157.84	20.84	25.99	21.79
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,364	1,334	763.19	475.97	425.77	415.82
Retained Earnings	-1,065	-972.43	-764.41	-425.62	-341.81	-276.01
Comprehensive Income & Other	0.79	0.18	0.3	-0.05	-0.02	0.01
Total Common Equity	299.28	361.98	-0.91	50.31	83.94	139.83
Shareholders' Equity	455.1	517.8	184.02	50.31	83.94	139.83
Total Liabilities & Equity	504.6	608.48	341.86	71.14	109.93	161.62
Total Debt	-	-	-	4.65	5.48	5.52
Net Cash (Debt)	486.2	603.09	339.28	51.07	87.65	140.75
Net Cash Growth	17.38%	77.76%	564.39%	-41.74%	-37.73%	110.62%
Net Cash Per Share	8.23	12.82	49.19	15.15	33.33	65.93
Filing Date Shares Outstanding	77.59	60.28	36.15	2.62	1.97	1.92
Total Common Shares Outstanding	60.47	60.26	36.06	2.61	1.97	1.92
Working Capital	458.33	554.41	309.55	47.6	78.75	133.35
Book Value Per Share	4.95	6.01	-0.03	19.24	42.52	72.89
Tangible Book Value	299.28	361.98	-0.91	50.31	83.94	139.83
Tangible Book Value Per Share	4.95	6.01	-0.03	19.24	42.52	72.89
Machinery	-	-	-	2.85	2.82	2.72
Leasehold Improvements	-	-	-	4.39	4.39	4.77

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q